AstraZeneca PLC (LON:AZN) posted better-than-expected core income in the fourth quarter, thanks to strong demand for its cancer and rare disease therapies that helped make…
View More AstraZeneca Q4 Core Earnings Beat Estimates Despite Esing COVID Vaccine Demand